# A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Suspension Injection of Investigational Capsid Inhibitors Compared to Placebo in Healthy Adults

> **NCT06012136** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **ViiV Healthcare** · enrollment: 85 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** VH4004280
- **DRUG:** Placebo
- **DRUG:** VH4011499

## Key facts

- **NCT ID:** NCT06012136
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-08-24
- **Primary completion:** 2026-06-09
- **Final completion:** 2026-06-09
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2025-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06012136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06012136, "A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Suspension Injection of Investigational Capsid Inhibitors Compared to Placebo in Healthy Adults". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06012136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*